Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Acclinate logo — Empowering Communities to Take Actions for Better Health

Acclinate

Empowering Communities to Take Actions for Better Health

Founded 2020 United States Birmingham, United States 60 employees Series A Total: $12.09M Biopharma, Health Care +1

General Information

Company Name Acclinate
Founded Year 2020
Location United States Birmingham, United States
Employees 60
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Series A
Business Model B2B, B2C, B2B2C
Revenue Model Service Fee, Data Monetization, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Acclinate. To contact Acclinate, visit acclinate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acclinate compare?

A PDF of Acclinate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acclinate soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acclinate

Acclinate, founded in 2020, is a dynamic company at the intersection of Biopharma, Health Care, and Pharmaceuticals, headquartered in the United States. With a mission encapsulated in their slogan, "Empowering Communities to Take Actions for Better Health", Acclinate leverages cutting-edge technology combined with grassroots community engagement. This approach aims to connect, educate, and empower underrepresented communities, especially in healthcare spaces.

In the rapidly evolving biopharma industry, Acclinate stands out by focusing on inclusivity and accessibility, aligning with broader healthcare trends emphasizing equity and diversity. Their recent $7.00M Series A investment received on 01 May 2024 from Cencora Ventures underscores investor confidence in their model and mission. As the company advances, it positions itself as a pivotal player in bridging gaps in healthcare access and engagement.

Business keywords: health tech, clinical trial diversity, AI/ML technology, health equity, personalized medicine, precision medicine, underrepresented communities, minority affairs, genomic data, clinical trial recruitment, regulatory strategy, site selection, program management, inclusion

Services & Products

Community-driven recruitment
AI-powered clinical trial solutions
Predictive enrollment intelligence
Culturally relevant engagement

Target Customers

Pharmaceutical Companies Contract Research Organizations (CROs) Healthcare Communities Underrepresented Populations in Clinical Trials

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $7.00M 1
Cencora Ventures
01 May 2024
Early VC $4.94M -
01 Oct 2022
Grant $100.00K 1
Google
Google
01 Sep 2021
Early VC Undisclosed -
01 Jan 2021
Early VC $50.00K 1
Alabama Launchpad
Alabama Launchpad
01 May 2020

Acclinate Alternatives & Competitors

View All Alternatives
Acclinate vs
Ancora.ai
Ancora.ai Switzerland

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to c...

Grant
9 employees
AI, Big Data
Compare Acclinate vs Ancora.ai
Acclinate vs
BEKhealth
BEKhealth United States

AI to find the right patients, right now.

Venture round
28 employees
Health Care, IT
Acclinate vs
Cisiv
Cisiv United Kingdom

Global integrated digital platform for non-interventional research, registries and Expanded Access P...

Seed
17 employees
Health Care, Information Technology
View all alternatives

FAQ About Acclinate

Empowering Communities to Take Actions for Better Health
Acclinate was founded in 2020.
Acclinate is headquartered in Birmingham, United States.
Acclinate operates in Biopharma, Health Care and Pharmaceutical. Its work centres on health tech, clinical trial diversity, AI/ML technology and health equity. Its customers include Pharmaceutical Companies, Contract Research Organizations (CROs) and Healthcare Communities.
Acclinate has a B2B, B2C and B2B2C business model. Its revenue comes from Service Fee, Data Monetization and Subscription.
Acclinate has approximately 60 employees.
Acclinate has completed 5 funding rounds, raising a total of $12.09M. The latest funding stage is Series A.
Acclinate offers: Community-driven recruitment, AI-powered clinical trial solutions, Predictive enrollment intelligence, Culturally relevant engagement.
Top alternatives and competitors to Acclinate include Ancora.ai, BEKhealth, Cisiv, Sano Genetics, Clariness. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acclinate and Ancora.ai are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acclinate, https://bouncewatch.com/company/acclinate, updated 4 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes